Venture Life Group plc (AIM:VLG)
London · Delayed Price · Currency is GBP · Price in GBX 67.40
-1.10 (-1.61%)
Sep 18, 2026, 1:15 PM GMT
Venture Life Group Market Cap
Venture Life Group has a market cap or net worth of 81.79 million as of September 18, 2026. Its market cap has increased by 13.55% in one year.
Market Cap
81.79M
Enterprise Value
48.29M
Revenue
35.17M
Ranking
n/a
PE Ratio
13.35
Stock Price
67.40
ChartMarket Cap Chart
Since March 28, 2014, Venture Life Group's market cap has increased from 26.08M to 81.79M, an increase of 213.56%. That is a compound annual growth rate of 9.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 81.79M | -2.05% |
| Dec 31, 2025 | 83.50M | 67.44% |
| Dec 31, 2024 | 49.87M | 17.68% |
| Dec 29, 2023 | 42.38M | -8.22% |
| Dec 30, 2022 | 46.17M | 22.31% |
| Dec 31, 2021 | 37.75M | -67.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.76B |
| GSK plc | 74.75B |
| Haleon | 29.92B |
| Smith & Nephew | 8.71B |
| INSPECS Group | 104.81M |
| Bioventix | 78.37M |
| 4basebio | 74.58M |
| Faron Pharmaceuticals Oy | 72.29M |